unitedhealthcare semaglutide UnitedHealth Group execs eye more affordable GLP-1s Semaglutide Micro-Dose 3-Month Plan |

The only publicly traded telehealth platform selling GLP-1s, Hims & Hers (HIMS), also uses this terminology.

44 The 52-week data from 966 patients with MASH and F1B, F2, or F3 fibrosis in the MAESTRO-NASH trial revealed significant effects of resmetirom on MASH resolution, fibrosis improvement, and LDL cholesterol reduction (NCT03900429), 77 forming the basis for potential FDA approval of resmetirom for MASH treatment

Document the incident and discuss it at your next appointment to prevent recurrence

Below is a framework comparing reported mental health effects from available data

High surfactant load, crystallizing actives, incompatible fragrance, corrosion particles or dried residue near the nozzle can restrict flow